Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 15/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.53 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.44 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10014684 | 0.97 | FBP1 (0.50) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL24833618 | 0.92 | FBP1 (0.55) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL14985142 | 0.90 | FBP1 (0.53) | P2RY2P2RY6P2RY4FBP1 | |
| SCHEMBL26074117 | 0.90 | FBP1 (0.53) | P2RY2P2RY6P2RY4FBP1 | |
| SCHEMBL13259502 | 0.90 | FBP1 (0.53) | P2RY2P2RY6P2RY4FBP1 | |
| SCHEMBL14985143 | 0.86 | FBP1 (0.56) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL23657026 | 0.86 | FBP1 (0.56) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL17319377 | 0.85 | P2RY2 (0.46) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL14619325 | 0.84 | FBP1 (0.56) | P2RY2P2RY6P2RY4FBP1P2RY14 | |
| SCHEMBL13002355 | 0.83 | FBP1 (0.43) | P2RY2P2RY6P2RY4FBP1P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007020018-A1 | USE OF PURINERGIC AND PYRIMIDINERGIC RECEPTOR AGONISTS FOR DENDRITIC CELLS BASED IMMUNOTHERAPIES | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2007-02-22 | — | — | WO | disclosed |